Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00006400Phase 3Completed
A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by National Heart, Lung, and Blood Institute. Started Aug 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00006400.